Event
Low Molecular Weight Heparin and Cancer Mortality: Too Good to be True?
Monday, March 20, 2023 12:30to13:30
Low Molecular Weight Heparin and Cancer Mortality: Too Good to be True?
Speaker: Marc Carrier, MD, MSc, FRCPC
Head of the Division of Hematology, The Ottawa Hospital
Professor, Faculty of Medicine, Department of Medicine
Senior Scientist in Clinical Epidemiology Program
The Ottawa Hospital Research Institute
Educational Objectives:
- To understand the mechanisms linking hypercoagulability and metastatic disease following cancer surgery
- To briefly discuss potential antimetastatic properties of low molecular weight heparin (LMWH)
- To review the results of the PERIOP-01 trial assessing the role of extended duration thromboprophylaxis with LMWH in patients undergoing localized colorectal cancer resection
Join the Medical Grand Rounds on .
Or call in (audio only) NEW: +1 438-799-0762, 502095193# Canada, Montreal, Phone Conference ID: 502 095 193#
The Medical Grand Rounds are an accredited group learning activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Some Rounds were .